Bayer Unveils Latest Funding for Digital Health Start-ups
The digital health start-ups selected for funding via Bayer’s Grants4Apps Accelerator programme have been revealed.
The Grants4Apps programme has been running since 2014, making it one of pharma’s most well-established digital health funds.
This year the scheme will foster four start-ups focused on medical adherence, endometriosis, atrial fibrillation, deep vein thrombosis, and ultrasound diagnostics by providing mentoring and 50,000 Euros in funding.
Those selected include London-based firm aparito which combines wearable technology, an app and a dashboard for professionals to transform data capture during clinical trials.
Aparito’s tech has been used in rare disease and oncological trials in the past.